- Home
- VERB vs GLMD Comparison
VERB vs GLMD Comparison
Compare VERB & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERB
- GLMD
- Stock Information
- Founded
- VERB 2014
- GLMD 2000
- Country
- VERB United States
- GLMD Israel
- Employees
- VERB N/A
- GLMD N/A
- Industry
- VERB Other Consumer Services
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- VERB Consumer Discretionary
- GLMD Health Care
- Exchange
- VERB Nasdaq
- GLMD Nasdaq
- Market Cap
- VERB 9.6M
- GLMD 3.0M
- IPO Year
- VERB N/A
- GLMD 2014
- Fundamental
- Price
- VERB $8.62
- GLMD $1.94
- Analyst Decision
- VERB Strong Buy
- GLMD Hold
- Analyst Count
- VERB 1
- GLMD 1
- Target Price
- VERB $62.00
- GLMD N/A
- AVG Volume (30 Days)
- VERB 23.4K
- GLMD 413.3K
- Earning Date
- VERB 08-13-2025
- GLMD 08-27-2025
- Dividend Yield
- VERB N/A
- GLMD N/A
- EPS Growth
- VERB N/A
- GLMD N/A
- EPS
- VERB N/A
- GLMD N/A
- Revenue
- VERB $2,193,000.00
- GLMD N/A
- Revenue This Year
- VERB $526.82
- GLMD N/A
- Revenue Next Year
- VERB $45.45
- GLMD N/A
- P/E Ratio
- VERB N/A
- GLMD N/A
- Revenue Growth
- VERB 3125.00
- GLMD N/A
- 52 Week Low
- VERB $3.81
- GLMD $1.15
- 52 Week High
- VERB $27.14
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- VERB 61.66
- GLMD 63.61
- Support Level
- VERB $7.00
- GLMD $1.74
- Resistance Level
- VERB $8.95
- GLMD $2.22
- Average True Range (ATR)
- VERB 0.62
- GLMD 0.13
- MACD
- VERB 0.13
- GLMD 0.02
- Stochastic Oscillator
- VERB 86.98
- GLMD 67.80
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.